Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6184 Target Snapshot

Transporter · SINGLE PROTEIN · Rattus norvegicus

352Compounds
37Assays
21Approved Drugs
377.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q63380. Use UniProt Q63380 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q63380 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Transporter as ChEMBL target CHEMBL6184, mapped to UniProt Q63380. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Transporter
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL6184
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q63380
Transporter
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Transporter is the right protein anchor across sources, using UniProt Q63380 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTransporter
UniProt AccessionQ63380
Component TypeProtein
Sequence Length617 aa

Transporter

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Transporter, mapped to UniProt Q63380. Sequence length is 617 aa.

Mapped IDQ63380
Review nameTransporter
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

21
Approved
2
Phase III
2
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5072.0
KI305.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL608151 9.87 Ki 0.1349 Preclinical
CHEMBL14370 9.16 Ki 0.69 Approved
CHEMBL72 9.11 Ki 0.78 Approved
CHEMBL393236 9.08 Ki 0.84 Preclinical
CHEMBL1173532 8.6 Ki 2.512 Preclinical
CHEMBL1175 8.52 Ki 3.0 Approved
CHEMBL180101 8.51 IC50 3.1 Clinical
CHEMBL552338 8.41 Ki 3.9 Preclinical
CHEMBL273575 8.4 Ki 4.0 Approved
CHEMBL641 8.4 Ki 4.0 Approved
Distribution

pChEMBL Value Distribution

65
5.0
67
5.5
46
6.0
29
6.5
22
7.0
17
7.5
16
8.0
3
8.5
3
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

MILNACIPRAN
CHEMBL259209
Approved 2009
DULOXETINE
CHEMBL1175
Approved 2004
ATOMOXETINE
CHEMBL641
Approved 2002
ZIPRASIDONE
CHEMBL708
Approved 2001
REBOXETINE
CHEMBL14370
Approved 1997
QUETIAPINE
CHEMBL716
Approved 1997
VENLAFAXINE
CHEMBL637
Approved 1993
PAROXETINE HYDROCHLORIDE
CHEMBL6067650
Approved 1992
CLOZAPINE
CHEMBL42
Approved 1989
FLUOXETINE
CHEMBL41
Approved 1987
FLUOXETINE HYDROCHLORIDE
CHEMBL1201082
Approved 1987
NOMIFENSINE
CHEMBL273575
Approved 1984
DESIPRAMINE
CHEMBL72
Approved 1964
AMPHETAMINE
CHEMBL405
Approved 1955
Assay Landscape

Assay Landscape

37
Total Assays
288
Tested Compounds
1
Assay Types
Binding — 37 assays, 288 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 11 135 6.3
single protein format 10 56 6.3
assay format 5 51 5.1
cell membrane format 5 35 5.6
subcellular format 4 3 6.0
cell-based format 2 8 7.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine